Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

Immunostimulatory gene therapy has been developed during the past twenty years. The aim of immunostimulatory gene therapy is to tilt the suppressive tumor microenvironment to promote anti-tumor immunity. Hence, like a Trojan horse, the gene vehicle can carry warriors and weapons into enemy territory...

Descripción completa

Detalles Bibliográficos
Autor principal: Loskog, Angelica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664972/
https://www.ncbi.nlm.nih.gov/pubmed/26561829
http://dx.doi.org/10.3390/v7112899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664972/
https://www.ncbi.nlm.nih.gov/pubmed/26561829
http://dx.doi.org/10.3390/v7112899

Ejemplares similares